Quest Diagnostics (NYSE:DGX) SVP Sells 5,662 Shares

robot
Abstract generation in progress

Quest Diagnostics (NYSE:DGX) SVP Patrick Plewman sold 5,662 shares of the company’s stock for over $1.15 million on February 10th, reducing his ownership by 26.91%. This comes after Quest Diagnostics reported better-than-expected Q4 earnings and revenue, raised its dividend, and authorized a $1 billion share buyback program. Analysts have largely maintained “Buy” or “Hold” ratings with an average target price of $208.93.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)